You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 10, 2025

Drug Price Trends for FT ADULT TUSSIN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for FT ADULT TUSSIN

Average Pharmacy Cost for FT ADULT TUSSIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
FT ADULT TUSSIN 200 MG/10 ML 70677-1186-02 0.01865 ML 2025-01-22
FT ADULT TUSSIN 200 MG/10 ML 70677-1186-01 0.02316 ML 2025-01-22
FT ADULT TUSSIN 200 MG/10 ML 70677-1186-02 0.01865 ML 2024-12-18
FT ADULT TUSSIN 200 MG/10 ML 70677-1186-01 0.02310 ML 2024-12-18
FT ADULT TUSSIN 200 MG/10 ML 70677-1186-02 0.01865 ML 2024-11-20
FT ADULT TUSSIN 200 MG/10 ML 70677-1186-01 0.02326 ML 2024-11-20
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for FT Adult Tussin

Overview of FT Adult Tussin

FT Adult Tussin, also known as Adult Tussin Cough and Chest Congestion DM, is a non-drowsy, alcohol-free medication designed to relieve cough and chest congestion. The active ingredients include dextromethorphan hydrobromide (20 mg per 10 mL) as a cough suppressant and guaifenesin (200 mg per 10 mL) as an expectorant[1][4].

Market Dynamics

Global Antitussive Drugs Market

The global antitussive drugs market, which includes products like FT Adult Tussin, is projected to grow significantly. As of 2022, the market was valued at USD 1,351.72 million and is expected to reach USD 1,878.58 million by 2030, growing at a CAGR of 4.20% during the forecast period[3].

Key Drivers

  • Surging Prevalence of Cough: Cough is a common reason for primary care visits, with a global annual prevalence estimated between 10% and 33% of the general population. This high prevalence drives the demand for antitussive drugs[3].
  • Increasing Healthcare Expenditure: Rising healthcare expenditure improves infrastructure and increases access to antitussive medications.
  • Rising Geriatric Population: The geriatric population, more prone to chronic ailments, is expected to increase significantly by 2050, further boosting the market[3].

Market Segmentation

Age Group

FT Adult Tussin is specifically formulated for adults and children aged 12 and above. The product is not intended for children under 12 years of age[1][4].

Distribution Channels

The product is available through various distribution channels, including retail pharmacies, online pharmacies, and hospital pharmacies. North America and Asia-Pacific regions are expected to dominate the market due to growing healthcare infrastructure and increasing geriatric populations[3].

Pricing and Cost Analysis

Current Pricing

The out-of-pocket price for FT Tussin DM Adult can vary, but it is typically around $13.41 per 118 mL bottle. However, with discounts and coupons, the price can be reduced to as low as $2.54 for the same quantity[5].

Price Projections

Given the growing demand and stable market growth rate, prices for FT Adult Tussin are likely to remain competitive. Here are some key points to consider:

  • Market Competition: The presence of similar products like Robitussin Cough + Chest Congestion DM and other generic alternatives keeps prices in check. Manufacturers often compare their products to these well-known brands to ensure competitive pricing[1][4].
  • Economic Factors: Rising healthcare expenditure and increasing demand due to the growing geriatric population may lead to slight price increases, but these are expected to be moderate.
  • Discounts and Coupons: The availability of discounts and coupons, such as those offered through SingleCare, can significantly reduce the out-of-pocket cost for consumers[5].

Regional Analysis

North America

North America is expected to dominate the antitussive drugs market due to the growing geriatric population and increasing healthcare expenditure. This region is likely to see stable to slightly increasing prices for FT Adult Tussin due to high demand and improving healthcare infrastructure[3].

Asia-Pacific

The Asia-Pacific region is also expected to grow during the forecast period, driven by surging government initiatives to improve healthcare infrastructure and increasing awareness about proper medication. Prices in this region may remain competitive due to local market dynamics and government regulations[3].

Key Takeaways

  • Market Growth: The global antitussive drugs market is projected to grow at a CAGR of 4.20% from 2022 to 2030.
  • Pricing Stability: Prices for FT Adult Tussin are expected to remain competitive due to market competition and the availability of discounts.
  • Regional Dynamics: North America and Asia-Pacific regions will drive the market growth, with prices influenced by local healthcare infrastructure and government initiatives.

FAQs

1. What are the active ingredients in FT Adult Tussin? The active ingredients are dextromethorphan hydrobromide (20 mg per 10 mL) and guaifenesin (200 mg per 10 mL)[1].

2. What is the recommended dosage for FT Adult Tussin? Adults and children 12 years and over should take 10 mL every 4 hours, not exceeding 6 doses in 24 hours[1].

3. Can FT Adult Tussin be used by children under 12 years? No, FT Adult Tussin is not intended for use in children under 12 years of age[1][4].

4. What are the potential side effects or warnings associated with FT Adult Tussin? Users should be cautious if taking MAOI drugs or if they have chronic cough conditions. The product should be stopped if cough lasts more than 7 days or is accompanied by fever, rash, or persistent headache[1].

5. How can I save money on FT Adult Tussin? You can save money by using coupons, joining loyalty programs, or purchasing through pharmacies that offer discounts[2][5].

Sources

  1. Drugs.com - Adult Tussin Cough and Chest Congestion DM.
  2. CVS Health - CVS Health Non Drowsy Long-Acting Tussin Adult Cough Suppressant.
  3. Data Bridge Market Research - Global Antitussive Drugs Market.
  4. Rite Aid - Rite Aid Adult Tussin Cough and Chest Congestion DM.
  5. SingleCare - FT Tussin DM Adult Coupons & Prices.

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.